The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Percent of subjects with binocular near visual acuity of 20/32 (logMAR 0.20) or better at six months postoperatively with distance correction in place measured at 40cm and 60cm. [ Time Frame: 6 months ]

binocular near visual acuity of 20/32 (logMAR 0.20) or better at six months postoperatively with distance correction in place measured at 40cm and 60cm.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

50 Years and older (Adult, Senior)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Willing and able to understand and sign an informed consent;

Willing and able to attend postoperative examinations per protocol schedule;

50 years of age or greater, of either gender or any race;

Less than (<) 1.00D of astigmatism in each eye, measured in their manifest refraction;

Mean refractive spherical equivalent refraction (MRSE) of +/- 0.50D for distance vision; Note: Subjects who meet this criterion as a result of prior laser refractive surgery (LASIK, LASEK or PRK) may qualify; however, the subject must have had the LVC procedure performed at least 12 months prior to the LaserACE® procedure and be stable.

Uncorrected distance visual acuity (UDVA) is better than or equal to 20/40 (logMAR 0.30) in each eye, and a Corrected Distance Visual Acuity (CDVA) is better than or equal to 20/25 (logMAR 0.10) in each eye;

Demonstrate Stereopsis of 100 seconds of arc or better using a Randot stereoscopic fly test and reading correction;

In good ocular health with the exception of presbyopia;

Presbyopia as demonstrated by:

Currently wearing reading glasses and/or bifocals with an ADD of +1.50D or more; and

Reduced near visual acuity when corrected for distance (DCNVA of 20/50 (logMAR 0.40) or worse; and

Amplitude of accommodation (AA) of 1.50D or less as measured by the minus lens test; OR

Amplitude of accommodation (AA) of 1.50D or less as measured by the iTrace aberrometer.

Less than or equal to (≤) 0.50D difference between the manifest refraction and the cycloplegic refraction;

Stable distance refraction is present, defined as ≤ 0.50D variation of refraction in the 12 months prior to the LaserACE® procedure. Manifest refraction cannot vary more than 0.50D from current spectacles that are at least 12 months of age, or from a documented refraction at least 12 months prior to the preoperative baseline exam;

Completed a washout period of two weeks (14 days) prior to LaserACE® procedure from prior treatment with:

NSAIDS, blood thinners, aspirin, and other substances which may increase bleeding;